Hyaluronic acid

Mechanism: Low-molecular-weight oral HA fragments are absorbed in the gut, distribute to skin and connective tissue, and signal fibroblasts to upregulate endogenous HA synthesis. The mechanism is partly direct substrate delivery and partly a gut-skin signaling pathway through HA-degrading microbes.

Oral HA at 120–240 mg/day for 6–12 weeks improves skin hydration and reduces measurable wrinkle volume in placebo-controlled trials. Effect sizes are modest — visible on replica imaging and corneometer, not transformative across the room — and the molecular weight on the label drives whether the product replicates trial conditions.

Strongest signal in adults with measurable baseline dryness or visible wrinkling, typically 35+. Younger skin with intact barrier function shows diminishing returns.

• Oe — oral hyaluronan for crow's-feet wrinkles

  positive

  Oe et al., 2017, Clinical, Cosmetic and Investigational Dermatology · rct · n=60 · industry-funded

  Daily 120 mg oral hyaluronan reduced wrinkle volume vs placebo on objective replica imaging by week 8 and held through week 12. Both 2 kDa and 300 kDa forms moved the needle, with the 300 kDa arm showing the cleaner separation from placebo on the primary endpoint.

  Industry-funded by a Japanese HA manufacturer. The study compared two HA molecular weights against placebo, not HA against an alternative active.

  PubMed

• Kawada — ingested hyaluronan for dry skin

  positive

  Kawada et al., 2014, Nutrition Journal · rct · n=81 · industry-funded

  Two parallel placebo-controlled trials in women with dry skin found significant gains in skin moisture from oral HA at both 240 kDa and 800 kDa over 6 weeks. Smaller sample sizes than Oe, but the moisture endpoint replicates across two cohorts within one paper.

  Industry-funded. Sample sizes (n=39 and n=42) are small and the population is self-reported dry skin rather than dermatologist-diagnosed.

  PubMed

Mechanism: Oral HA does not become injected viscosupplementation — the polymer chains do not survive digestion to lubricate joints directly. The proposed mechanism is gut-derived oligosaccharide signaling that dampens synovial inflammation, supported by Nelson's drop in synovial-fluid bradykinin and inflammatory markers.

Two RCTs in knee OA patients (12-month Tashiro at 200 mg/day, 3-month Nelson with proprietary Oralvisc) showed pain and function improvements vs placebo, with a measurable mechanistic biomarker shift in synovial fluid. Smaller body of evidence than for skin, but consistent direction.

Knee OA has the only direct trial signal. Hip OA, shoulder OA, and general non-OA aches have not been tested. Oral HA does not replicate the effect of intra-articular HA injection — that is a separate intervention.

• Tashiro — oral hyaluronic acid for knee osteoarthritis

  positive

  Tashiro et al., 2012, The Scientific World Journal · rct · n=60 · industry-funded

  One year of 200 mg/day oral HA on top of a standardized quadriceps strengthening program reduced knee OA symptom scores vs exercise alone, with the strongest effect in patients aged 70 or younger. The 12-month duration is unusual for an oral HA trial and gives the result more weight than typical 8-week skin studies.

  Industry-funded. The active arm received HA on top of the same exercise prescription as placebo, so this isolates the supplement contribution but not from regression-to-the-mean over a long follow-up.

  PubMed

• Nelson — Oralvisc oral HA preparation for obese knee OA

  positive

  Nelson et al., 2015, Rheumatology International · rct · n=40 · industry-funded

  Three months of an oral HA preparation in 40 obese knee OA patients improved pain and function scores vs placebo and lowered synovial-fluid bradykinin and pro-inflammatory cytokines. Independent replication of the Tashiro signal in a different population, with a mechanistic biomarker layer on top.

  Small sample. Multi-component formulation — HA is the headline active but the product also contained other glycosaminoglycans, which limits HA-only attribution.

  PubMed

Mechanism: HA is a major glycosaminoglycan in skin, joints, eyes, and connective tissue. Oral supplementation modestly raises plasma HA and tissue HA in animal work; the human evidence is concentrated on skin and joint endpoints rather than systemic markers.

Beyond skin and knees, the broader 'connective tissue support' claim leans on mechanism rather than direct trials. Useful as a daily add-on for adults focused on skin and joint aging in midlife, less compelling as a standalone wellness supplement in younger healthy adults.

Most rationale for adults 35+ with skin or joint complaints. The general-wellness use case is not directly RCT-supported.

• Oe — oral hyaluronan for crow's-feet wrinkles

  positive

  Oe et al., 2017, Clinical, Cosmetic and Investigational Dermatology · rct · n=60 · industry-funded

  Daily 120 mg oral hyaluronan reduced wrinkle volume vs placebo on objective replica imaging by week 8 and held through week 12. Both 2 kDa and 300 kDa forms moved the needle, with the 300 kDa arm showing the cleaner separation from placebo on the primary endpoint.

  Industry-funded by a Japanese HA manufacturer. The study compared two HA molecular weights against placebo, not HA against an alternative active.

  PubMed

• Kawada — ingested hyaluronan for dry skin

  positive

  Kawada et al., 2014, Nutrition Journal · rct · n=81 · industry-funded

  Two parallel placebo-controlled trials in women with dry skin found significant gains in skin moisture from oral HA at both 240 kDa and 800 kDa over 6 weeks. Smaller sample sizes than Oe, but the moisture endpoint replicates across two cohorts within one paper.

  Industry-funded. Sample sizes (n=39 and n=42) are small and the population is self-reported dry skin rather than dermatologist-diagnosed.

  PubMed

• Low-molecular-weight hyaluronic acid (< 5 kDa)INJUV, ExceptionHAHigh — small fragments absorb intact through gut epithelium
  Best for: Skin hydration and wrinkle reduction; joint support
  The form most consistent with the absorption signal. Branded options like INJUV disclose molecular weight on spec sheets. If a product says 'low molecular weight HA' but won't give a kDa range, the disclosure is marketing rather than verification.
  skin: 80–240 mgbone: 100–240 mg
• Low-density hyaluronic acid (small fragments)High when molecular weight is genuinely low
  Best for: Skin hydration
  'Low density' is a marketing term that overlaps with low molecular weight but is not a regulated descriptor. Look for an actual kDa figure on the spec sheet.
• Hydrolyzed hyaluronic acidVariable — depends on degree of hydrolysis and final fragment size
  Best for: Skin and joint support
  Hydrolysis is the manufacturing step that converts polymer HA to absorbable fragments. Without disclosed final molecular weight, you cannot tell if the hydrolysis was deep enough to produce trial-grade material.
• Sodium hyaluronate (oral)Scales with molecular weight — high-MW forms are poorly absorbed
  Best for: General oral HA supplementation
  Sodium hyaluronate is the salt form of HA used in most products. Oral absorption depends on molecular weight, which most labels do not disclose. The same name on a label can describe a 5 kDa fragment or a 1 MDa polymer chain — completely different products from an absorption standpoint.
• Hyaluronic acid (molecular weight not disclosed)Unknown without MW disclosure
  Best for: Marketing — depends on what's actually in the capsule
  If the label says 'hyaluronic acid' with no molecular weight and no branded source, you are paying for an unknown. The mg dose may match the trials; the molecular form that drives the trial result may not be there.
  skin: 120–240 mg

• !Molecular weight on the label is the entire story for oral HA. The trials that worked used disclosed low-to-mid-MW HA (2 kDa to 800 kDa). High-molecular-weight polymer chains in '1000 mg' marketing capsules do not penetrate the gut intact. If the label is silent on MW, the dose number is decorative.
• !Oral HA is not the same product as injectable HA. Knee viscosupplementation injections (Synvisc, Hyalgan) and dermal fillers (Juvederm, Restylane) deliver HA directly to the target tissue at high concentrations. Oral HA has a separate mechanism through gut absorption and signaling — they are not interchangeable products.
• !Topical HA serums sit on the skin surface and pull water in from the air or the dermis. They do not enter the bloodstream and cannot replicate the systemic effects of oral supplementation. A topical and an oral are complementary, not redundant.
• !Most retail oral HA products under-dose for skin. The trials used 120–240 mg/day. Many gummies and skin-and-hair multivitamins provide 20–50 mg per serving — well below the threshold where the skin-hydration signal lands.
• !'Vegan' or 'fermentation-derived' HA is fine. Modern oral HA is overwhelmingly produced by Streptococcus or Bacillus fermentation, which is both vegan-compatible and free of the avian-allergy risk that dogged older rooster-comb extracts. Sourcing claims are mostly marketing differentiators.

• What's the best form of oral hyaluronic acid?▾

  Low-molecular-weight HA (under ~5 kDa) with the molecular weight disclosed on the spec sheet. Branded forms like INJUV and ExceptionHA publish their molecular-weight ranges; generic 'hyaluronic acid' or 'sodium hyaluronate' without MW disclosure is a coin flip. The Oe 2017 trial showed both 2 kDa and 300 kDa fragments work for wrinkle volume — what doesn't work is undisclosed polymer.
• How much oral hyaluronic acid should I take?▾

  120–240 mg/day for skin hydration and wrinkle reduction. 100–200 mg/day for knee osteoarthritis. Most retail capsules contain 50 mg or less, well below the trial doses. If you take a 50 mg gummy, expect 50 mg results.
• Does oral HA work as well as a serum or an injection?▾

  They are different products that do different things. Topical serums hydrate the surface of the skin and don't enter circulation. Injections deliver HA directly to a joint or dermal layer at high concentration. Oral HA works through systemic absorption and signaling — modest, measurable effects on skin moisture and OA symptoms, not the dramatic localized effect of an injection.
• How long until I see results?▾

  6 weeks for measurable skin moisture changes. 8–12 weeks for wrinkle-volume reduction on replica imaging. 3–12 months for knee OA pain improvement. Skin gains tend to taper over a few weeks after stopping; joint gains require ongoing dosing.
• Is HA safe for vegetarians and vegans?▾

  Most modern oral HA is vegan — it is produced by bacterial fermentation (typically Streptococcus equi or Bacillus subtilis) rather than extracted from rooster combs. Older animal-derived HA still exists in some products; if vegan sourcing matters, look for 'fermentation-derived' or 'vegetable origin' on the label.